LMN-201 for Prevention of C. Difficile Infection Recurrence
Status:
Not yet recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
This is a multisite study to evaluate the safety, tolerability, and efficacy of LMN-201 in
participants recently diagnosed with CDI who are scheduled to receive or are receiving SOC
antibiotic therapy against C. difficile.